Study identifier:D7680C00001
ClinicalTrials.gov identifier:NCT06192004
EudraCT identifier:N/A
CTIS identifier:N/A
An Observational, Prospective, Multicenter Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy with Risk of Pneumonitis/ILD
Non-small Cell Lung Cancer
N/A
No
-
All
600
Observational
18 Years - n/a
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Prospective Cohort NSCLC patients initiating an approved treatment with risk of pneumonitis/ILD. | - |